The Mosaic Company (MOS) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call summary presents a mixed outlook. While there are positive aspects like potential working capital release from excess inventory and optimistic production targets, there are also challenges such as farmer affordability issues and high sulfur prices impacting margins. The Q&A indicates management's optimism but also highlights uncertainties, particularly in pricing and cost management. Overall, the sentiment is balanced with both positive and negative factors, leading to a neutral stock price prediction.
Key Financial Performance
Phosphate Fertilizer Production Produced 1.7 million tonnes in Q4 2025, despite an extended turnaround at the Bartow facility and deliberate production adjustments due to soft U.S. demand. Production is expected to reach at least 7 million tonnes in 2026.
Potash Production Produced around 9 million tonnes in 2025, with expectations to maintain similar levels in 2026. Esterhazy operations are back at full rates after a fatality in December, and the HydroFloat project is ramping up.
Cash Cost of Conversion (Phosphate) Improved to $112 per tonne in Q4 2025, a $20 per tonne improvement compared to earlier in the year. This improvement is structural and not one-off.
Cash Cost of Production (Potash) Averaged $75 per tonne in 2025, though higher costs were incurred due to the extension of Colonsay.
Blended Rock Cost per Tonne (Mosaic Fertilizantes) Reached $97 in 2025, the lowest level since 2021.
Cost Savings Achieved $150 million in cost savings ahead of schedule in 2025.
Net Sales (Mosaic Biosciences) Doubled to $68 million in 2025, with stable gross margins in the 40% range.
Working Capital Impact on Cash Flow Reduced cash flow by $960 million in 2025, contributing to an $829 million increase in net debt.
Sulfur Price Impact Every $10 increase in sulfur prices adds approximately $10 million of quarterly expense. A $250 million headwind to Q1 2026 EBITDA is expected due to sulfur price increases.
Excess Inventory (Phosphates) Exited 2025 with 240,000 tonnes of excess inventory, representing roughly $140 million of potential working capital release over the next few quarters.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Mosaic Biosciences: Launched five new products in 2025 and expanded commercialization in the Americas, China, and India. Achieved 60+ registrations and sales in 16 countries. Doubled net sales to $68 million in 2025. Plans to launch 8-10 new products in 2026, aiming to double net sales again.
Market Access: Expanded Brazil distribution capacity with a 1 million tonne blending facility in Palmeirante, Northern Brazil. This positions the company to meet rising demand as credit conditions normalize.
Market Share: Despite a decline in overall North America potash and phosphate shipments in 2025, Mosaic's North America sales volumes were more resilient, indicating additional market share capture.
Phosphate Production: Improved phosphate production performance in 2025, with Florida reaching its highest level in three years and record mining production at Miski Mayo. Produced 1.7 million tonnes in Q4 2025 and expects to produce at least 7 million tonnes in 2026.
Potash Production: Achieved consistently good potash production in 2025 and expects record production at Esterhazy in 2026. Plans to produce around 9 million tonnes of potash in 2026.
Cost Management: Achieved $150 million cost savings in 2025 ahead of schedule. Improved cash cost of phosphate conversion by $20 per tonne in Q4 2025. Potash production costs averaged $75 per tonne in 2025. Plans to deliver another $100 million in savings in 2026.
Asset Divestitures: Divested non-core assets, including Patos de Minas, Taquari, and a pending Carlsbad transaction, generating $170 million in proceeds and reducing $60 million in asset retirement obligations.
Capital Allocation: Plans to invest $1.5 billion in capital expenditures in 2026, focusing on mine and infrastructure expansions in Florida. Expects capital expenditures to trend down to $1 billion by 2030.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Phosphate Demand Challenges: U.S. phosphate demand fell sharply in Q4 2025 due to affordability challenges and uncertainties surrounding government support. This could strain logistics capabilities during a compressed demand timeframe in 2026.
Sulfur Price Volatility: A sharp increase in sulfur prices at the end of 2025 is expected to significantly compress margins in the Phosphate and Mosaic Fertilizantes segments well into the first half of 2026.
Brazil Operations: Credit constraints in Brazil remain a challenge, leading to the idling of Araxa and Fospar, the company's lowest-margin operations, until further notice.
Working Capital and Cash Flow Constraints: Inventory builds in finished products and raw materials in 2025 reduced cash flow by $960 million, contributing to an $829 million increase in net debt. This has constrained near-term cash flow and impacted debt management plans.
Production Recovery Delays: The recovery of production volumes in the U.S. Phosphate business has taken longer than expected, impacting operational stability and cost normalization efforts.
Environmental and Capital Expenditures: Capital expenditures are expected to rise in 2026 due to mine, gyp stack, and clay settling area expansions in Florida, increasing financial pressure.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Phosphate Production: Mosaic expects to produce at least 7 million tonnes of phosphate in 2026, with consistently good production levels anticipated.
Potash Production: The company anticipates record production at Esterhazy in 2026 and expects to produce around 9 million tonnes of potash, similar to 2025 levels.
Global Potash Shipments: Global potash shipments are expected to approach record levels in 2026, driven by broad-based demand across key geographies.
Brazilian Fertilizer Demand: Expanding planted acreage and rising crop yields are expected to support long-term fertilizer demand in Brazil, despite current credit constraints.
Mosaic Biosciences Growth: Mosaic Biosciences expects to double net sales again in 2026, driven by continued adoption of its current portfolio and 8 to 10 new product launches.
Cost Savings Initiatives: The company aims to deliver another $100 million in savings in 2026 through technology-enabled initiatives and operational efficiencies.
Capital Expenditures: CapEx is projected to be around $1.5 billion in 2026, higher than 2025, due to mine, gyp stack, and clay settling area expansions in Florida. However, CapEx is expected to trend down to approximately $1 billion by 2030.
Asset Retirement Obligations (ARO) and Environmental Reserves: Cash spending on ARO and environmental reserves is expected to decline by roughly $50 million in 2026 and trend down to about $200 million by 2030.
Working Capital and Cash Flow: A $300 million to $500 million working capital release is anticipated in 2026, supporting higher cash flow generation. EBITDA to cash flow conversion is expected to improve significantly from 2025 levels.
Phosphate Margins: Margins in the Phosphate and Mosaic Fertilizantes segments are expected to remain compressed in the first half of 2026 due to high sulfur prices.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Minimum Dividend: The company expects to generate free cash flow after CapEx and other cash spend above the minimum dividend in 2026.
Extraordinary Returns to Shareholders: The company plans to prioritize debt reduction and subsequently pave the way to resume extraordinary returns to shareholders.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you triangulate your thoughts on phosphate or DAP pricing and its impact on farmers' purchasing decisions?
A:Management acknowledged that farmer affordability remains a challenge, though it is expected to improve in 2026. They noted that passing through higher sulfur prices may be limited due to affordability issues. However, they remain optimistic about maintaining profitability with stripping margins above $300. They also highlighted differences in market dynamics between North America and international markets, with international DAP prices being higher due to government subsidies in countries like China and India.
Q:Can you provide an update on phosphate production and asset portfolio for 2026?
A:Management stated that they are targeting an 8 million tonne production rate, requiring an 80% operating factor across facilities. They reported progress in achieving this target, with facilities like Bartow and Louisiana already operating at 80%. New Wales is undergoing a turnaround and is expected to reach 80% in Q2. They remain optimistic about achieving their production and cost goals, including reducing conversion costs below $100 per tonne.
Q:Where does the ARO and environmental reserves cash spend appear in the financial statements?
A:The ARO and environmental reserves cash spend is spread across several lines in the operational part of the cash flow statement, including accrued liabilities and net income adjustments. It does not appear under capital expenditures.
Q:Why is CapEx increasing in 2026, and will it extend into 2027?
A:CapEx is increasing due to the timing of multiple waste disposal projects, including gypsum stacks and clay settling areas. Management considers the $1.5 billion CapEx as a ceiling and expects it to decline in subsequent years. They are confident that these projects will not extend into 2027.
Q:What is the reason for excess phosphate rock inventory, and how will it be managed?
A:Excess phosphate rock inventory resulted from lower fertilizer production due to asset reliability issues. Management plans to reduce this inventory as production rates improve, potentially releasing $170-$180 million in value.
Q:What is the volume outlook for Fertilizantes in 2026?
A:Management expects challenges in Brazil due to credit issues and high interest rates, which may result in flat fertilizer shipments. They plan to make prudent decisions on sales and credit risk, focusing on long-term market growth and yield improvements.
Q:Why has U.S. phosphate demand been down despite strong crop yields?
A:Management attributed the decline to reduced fall applications in 2025, which may impact yields in the current crop season. They also noted that precision agriculture and biologicals are helping farmers optimize fertilizer use.
Q:What changed with the 2 million tonnes per quarter phosphate production target?
A:Management clarified that their guidance is based on trailing demonstrated performance, which may result in upside potential. They remain confident in achieving full utilization to hit 8 million tonnes annually.
Q:What is the expected product and geographic mix for phosphate in 2026?
A:Management expects a potential increase in international phosphate sales due to constrained Chinese exports, which could reduce the percentage sold in North America.
Q:How does the U.S. countervailing duties review process work, and what is its impact?
A:The sunset review process for countervailing duties will begin in April 2026. Duties will remain in place until a decision is made, and there is no direct correlation between the review and current phosphate market prices.
Q:What is the impact of high sulfur prices on Fertilizantes' EBITDA?
A:High sulfur prices led to production curtailments and lower distribution margins, resulting in $50 million EBITDA in Q4. Management expects improved performance as production normalizes and distribution margins expand.
Q:Why did U.S. farmers apply potash without phosphate in 2025?
A:Farmers prioritized potash due to its affordability compared to phosphate and nitrogen. Some farmers delayed phosphate applications, hoping for price resets, which did not occur.
Q:What is the impact of sulfur prices on phosphate stripping margins?
A:Higher sulfur prices in Q1 2026 may increase costs, but management expects some offset from declining ammonia prices and improved fixed cost absorption. They estimate a breakeven stripping margin of $250 per tonne.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the specific sulfur cost assumptions for Q1 2026 and provided limited details on the exact impact of sulfur price fluctuations on quarterly stripping margins.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
ARO environmental
America global
America potash
America sale
Americas China
Biosciences
China India
Florida
PO
Phosphate
area
asset retirement
capital expenditure
cash cost
cash spending
cost tonne
efficiency progress
effort
geography
market access
market condition
output
platform
portfolio
potash shipment
proceeds
product launch
production tonne
progress front
record level
registration
reserve
retirement obligation
review
rock
share
start
transaction Carlsbad
MOS Transcript
The Mosaic Company (MOS) Q1 2026 Earnings Call Transcript
Unknown5-11
The earnings call summary reveals a decline in key financial metrics, including revenue, gross margin, net income, and EPS, all down significantly year-over-year. The absence of discussions on operational updates, strategic initiatives, or shareholder returns suggests a lack of positive catalysts. The Q&A section provided no additional clarity or positive sentiment. The forward-looking statements highlight significant risks, and no guidance or optimistic outlook was offered to counterbalance the negative financial results. These factors collectively suggest a negative sentiment, likely leading to a stock price decline of -2% to -8%.
The Mosaic Company (MOS) Q4 2025 Earnings Call Transcript
Unknown2-25
The earnings call summary presents a mixed outlook. While there are positive aspects like potential working capital release from excess inventory and optimistic production targets, there are also challenges such as farmer affordability issues and high sulfur prices impacting margins. The Q&A indicates management's optimism but also highlights uncertainties, particularly in pricing and cost management. Overall, the sentiment is balanced with both positive and negative factors, leading to a neutral stock price prediction.
The Mosaic Company (MOS) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call shows strong demand and stable prices in phosphate and potash markets, with positive EBITDA expectations. However, concerns over workforce turnover, institutional knowledge gaps, and potential demand deferral in Q4 phosphate sales create uncertainties. Despite operational improvements and cost reduction plans, the unclear management responses in the Q&A section add to the mixed sentiment. The neutral rating reflects these balancing positive and negative factors.
The Mosaic Company (MOS) Q2 2025 Earnings Call Transcript
Unknown8-6
Despite some positive aspects like improved production in August and strong performance in Biosciences, there are concerns over extraordinary phosphate costs and unclear responses regarding cost ramp-down. Positive factors like increased potash production and potential Q3 EBITDA growth are balanced by these uncertainties, leading to a neutral sentiment. The lack of specific guidance on certain issues and the market's negative reaction to extraordinary expenses add to the mixed outlook.
MOS Slides
MOS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
